Blue Star E&E's MedTech Business Sale to Cyrix Completed
Blue Star E&E's MedTech business has been transferred to Cyrix, effective September 1, 2026. The sale consideration is up to ₹40 crore, payable in tranches by March 31, 2027. The MedTech division's income was ₹42.13 crore in FY26, representing 0.33% of consolidated income.
The MedTech business contributed a small fraction (0.33%) of the company's consolidated income and net worth, indicating a limited financial impact on Blue Star Limited.
The transaction is a routine business divestment to focus on strategic priorities. While it involves a sale, the financial impact on the overall consolidated results appears to be minor based on the provided figures.
Blue Star Limited has announced the completion of the sale and transfer of the MedTech business of its wholly-owned subsidiary, Blue Star Engineering & Electronics Limited (Blue Star E&E), to Cyrix Healthcare Private Limited (Cyrix).
The transfer was effective from September 1, 2026, with confirmation received from Cyrix on September 1, 2026, at 11:30 PM. This sale follows the execution of a Business Transfer Agreement (BTA) on August 14, 2026, for the disposal of the high-end medical diagnostic equipment and services business on a slump sale basis.
The consideration for the sale is up to ₹40 crore (Rupees Forty Crores), payable in tranches, with the final payment due by March 31, 2027. The MedTech division generated an income of ₹42.13 crore in the financial year ended March 31, 2026, representing approximately 0.33% of the consolidated income. Its net worth as of March 31, 2026, was approximately ₹7.11 crore, constituting about 0.21% of the consolidated net worth.
Cyrix Healthcare Private Limited is a pan-India Total MedTech Management Solutions provider with over 22 years of experience and is not part of the Promoter or Promoter Group of Blue Star Limited. The transaction does not fall within related party transactions and is outside the scope of any Scheme of Arrangement. The business transfer is undertaken to allow Blue Star Limited to focus on its strategic priorities. The company has placed this information on its website, www.bluestarindia.com.
A plain-language summary of a public exchange filing by Blue Star Limited. Read the original for the full detail.